Delivery Order SPE2DB20D9331-SPE2DB23FL1L9

Award Date 8/30/23
Potential Completion Date 8/31/23
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,123.76 contract is to provide a 4 mL solution of 4% Lidocaine HCl. This delivery order is issued under DMS Pharmaceutical Group's existing $499,999,999 Indefinite Delivery Contract (IDC) with the DLA to supply a comprehensive range of branded and generic prescription drugs,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,088.99 contract is for the delivery of Lidocaine Ointment to support the recurring pharmaceutical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,107.48, is for the supply of 50ml vials of 1% lidocaine with 1:100,000 epinephrine. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, to provide a comprehensive range of...
The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Lidocaine HCL 1% syringe 5ML. The one-year contract, with a potential value of $2,303.49, was awarded on January 25, 2024 and will run through January 26, 2024. This delivery order is likely part of a larger indefinite delivery contract, contract 4600082013 under the SPE2DB program, valued at up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,011.00, is a firm fixed-price delivery order for the supply of Lidocaine Hydrochloride, a specialized pharmaceutical product. The contract is not associated with a set-aside designation, which allows DMS Pharmaceutical Group to leverage its status as a woman-owned small...
The Defense Logistics Agency awarded a $2,011.38 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 100ml bottles of 2% viscous lidocaine solution. As a prime contractor on an indefinite-delivery/indefinite-quantity contract vehicle, DMS will deliver the requested pharmaceutical to a customer located in Park Ridge, Illinois by July 28, 2023. No set aside designation or subcontracting details were provided. This award supports the DLA's mission to provide medical...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at one thousand three hundred forty dollars and ninety-two cents ($1,340.92) to DMS Pharmaceutical Group Inc. to supply one hundred milliliters (100mL) of lidocaine 2% viscous solution. The place of performance is Park Ridge, Illinois. The period of performance is one day, from September 6, 2023 through September 7, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency...
The Defense Logistics Agency awarded a $287 delivery order to DMS Pharmaceutical Group Inc. for 100ml bottles of 2% viscous lidocaine solution. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle to supply pharmaceutical products and medical supplies to various DOD customers. Performance will take place in Park Ridge, Illinois over a four day period from August 4-7, 2023. No set aside designation or subcontractors were identified. This order supports the...
This is a $7,593.60 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of 4,563,767,512 units of Lidocaine 5% Patch 30s, with a completion date of February 27, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency...
This federal contract award, with ID SPE2DX15D9114|SPE2DX24F5ZZF, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,168.96 firm fixed-price delivery order is for the supply of various pharmaceutical products, including Lidocaine HCL 2% 200 mg/10 mL, to support the recurring medical supply needs of military health facilities...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB23FL1L9
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $3,722.35 order is for the supply of Lidocaine 2% Viscous Solution 100mL, a common medication, to support the recurring medical supply needs of military health facilities.

The award is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to place delivery orders for a comprehensive range of pharmaceutical products. This IDC, under the DLA's SPE2DB program, is a crucial contract vehicle that solidifies DMS Pharmaceutical Group's position as a key supplier in the federal pharmaceutical supply chain, providing both routine and critical medications to Department of Defense (DoD) healthcare facilities worldwide. The contract has no set-aside designation.

Generated 1/9/25, 9:23 AM